Download presentation
Presentation is loading. Please wait.
Published byElvin Blair Modified over 6 years ago
1
Children in Research: They’re Not Just Small Adults
5/13/2018 4:06 PM Children in Research: They’re Not Just Small Adults Kelly O’Berry IRB Education & Outreach Manager Human Subjects Photo by Zachary Scott, 1981, for the New York Times © 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
2
Overview Pros and Cons of Using Children as Subjects
Ethical Principles Federal Regulations and Guidance Consent/Assent Resources
3
Children as Research Subjects
Pros: Cons Risks from taking medication that has not been tested in children Regulations allow parent/guardian to grant permission Children’s Health Act of 2000 Diseases only in kids Risks from investigational medication and study procedures lack legal authority to consent for themselves Historic cases of unethical research
4
Ethical Principles: Respect for Persons Beneficence Justice
Provisions for parental permission Considerations for the child Beneficence Discoveries that benefit children Justice Research must be done in adults before children, whenever possible Photo by Zachary Scott, 1981, for the New York Times
5
Regulations & Guidance
Photos by Zachary Scott, 1981, for the New York Times
6
Subpart A (The Common Rule)
Definitions Legally Authorized Representative Criteria for IRB Approval (45 CFR ) Minimize Risk to Subjects Risk/Benefit Evaluation Informed Consent will be sought and documented Additional Safeguards for Vulnerable Subjects
7
Common Rule (continued)
Obtaining Informed Consent From subject or Legally Authorized Representative Circumstances minimize coercion or undue influence Language the subject or LAR can understand Presenting the required information (elements of consent)
8
Expedited Review Limits amount of blood collected, based on subject’s:
Age Weight Health
9
Subpart D: Children Definitions Limits on Exempt Research Children
Parent Guardian Limits on Exempt Research NOT surveys or interviews Observation of public behavior - ONLY if researcher not participating in the activities being observed
10
Subpart D – Risk and Benefit
The IRB Can approve studies that are: No greater than minimal risk Greater than minimal risk, but include the prospect for direct benefit Greater than minimal risk and no prospect for direct benefit, but likely to yield generalizable knowledge of subject’s disorder or condition
11
The IRB Cannot Approve:
Studies that are more than minimal risk, no prospect for direct benefit and not likely to yield generalizable results about the subject’s condition, but opportunity to further understand, prevent or alleviate a serious problem affecting health/welfare of children
12
Approval Process for Studies the IRB Cannot Approve
Department of Health and Human Services (HHS) Posts Protocol in Federal Register Time for Public Comment Convene an expert panel Protocol approved by the HHS Secretary 8-week process
13
Wards of the State Only the first 2 IRB approval categories if:
Research is related to their status as a Ward Research is done in a setting where the majority of child subjects are not Wards Requires appointment of an advocate in addition to the Guardian
14
Subpart B: Pregnant Women, Fetuses and Neonates
Scope Consent/Permission from the Woman Benefit to herself Benefit to herself and fetus No benefit (minimal risk to fetus and purpose to develop important biomedical knowledge) Permission from Both Parents Prospect of benefit only for the fetus
15
Subpart B (continued) Pregnant Teens
Follow Subpart D (research with children) Limitations on what Researchers can do No inducements No part in decision-making No determination about viability
16
Subpart C: Prisoners Definitions
Must comply with requirements of Subpart B and Subpart C
17
Informed Consent & Assent
Photo by Zachary Scott, 1981, for the New York Times
18
Parent/Guardian Permission
Granting permission – not consent All required elements of consent Voluntary agreement for child to participate
19
Anticipate and Address Needs
Reluctance to ask questions Concerns about “experiments” & research Bad experience with health care/research Difficulty understanding words/concepts Confuse healthcare and research (therapeutic misconception Coercion or undue influence
20
Consent Document Use IRB template Fill in study details
When to use “your child” in place of “you” Could describe both the parent and child participation in the study Could collect information about the child from a proxy (parent, teacher, other)
21
Documenting Parent Permission
Valid IRB Approval Stamp Subject Printed Name Subject Signature & Date, if applicable Parent/Guardian Section Good: Mother, Father, Legal Guardian Questionable: Step Parent, Foster Parent, Grandparent, Aunt/Uncle, Other… Record Storage Requirements
22
Assent from the Child Obtain Assent Read and Sign
Read and Verbal Agreement Verbal Description and Agreement No Assent Not capable Prospect for direct benefit Waiver of assent
23
Assent Document Template Assent Document
Simpler description of the study Printed name, signature and date Edit to reflect the proposed assent process
24
Resources UI Investigator’s Guide Federal Regulations – HHS and FDA
Family Education Rights and Privacy Act (FERPA) Guidance from the Office of Human Research Protections (OHRP) Special Protections for Children as Subjects FAQ on Research with Children Guidance from the Food and Drug Administration (FDA) General Considerations for the Clinical Evaluation of Drugs in Infants and Children Children and Clinical Studies.org
25
Questions/Comments? Photo by Zachary Scott, 1981, for the New York Times
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.